BRIEF-Express Scripts says may change formulary in mid-2015 due to "unsustainable" cost of Gilead's Sovaldi

Oct 29 (Reuters) - Express Scripts Holding Co : * Says may change drug formulary in mid-2015 to favor expected new hepatitis c
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.